Cite
Rifkin RM, Bell JA, DasMahapatra P, et al. Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma. Pharmacoecon Open. 2020;4(3):473-483doi: 10.1007/s41669-019-00184-9.
Rifkin, R. M., Bell, J. A., DasMahapatra, P., Hoole, M., Lowe, M., Curran, C., Campbell, S., Hou, P., & Romanus, D. (2020). Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma. PharmacoEconomics - open, 4(3), 473-483. https://doi.org/10.1007/s41669-019-00184-9
Rifkin, Robert M, et al. "Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma." PharmacoEconomics - open vol. 4,3 (2020): 473-483. doi: https://doi.org/10.1007/s41669-019-00184-9
Rifkin RM, Bell JA, DasMahapatra P, Hoole M, Lowe M, Curran C, Campbell S, Hou P, Romanus D. Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma. Pharmacoecon Open. 2020 Sep;4(3):473-483. doi: 10.1007/s41669-019-00184-9. PMID: 31605300; PMCID: PMC7426337.
Copy
Download .nbib